These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37382078)

  • 1. Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients.
    Bocci S; D'Alessandro M; Bergantini L; Cerase A; Ulivelli M; Rottoli P; Cavallaro D; Gangi S; Bargagli E; Giannini F
    Sarcoidosis Vasc Diffuse Lung Dis; 2023 Jun; 40(2):e2023019. PubMed ID: 37382078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krebs von den Lungen-6 as a Potential Predictive Biomarker in Fibrosing Interstitial Lung Diseases.
    Lederer C; Mayer K; Somogyi V; Kriegsmann K; Kriegsmann M; Buschulte K; Polke M; Findeisen P; Herth F; Kreuter M
    Respiration; 2023; 102(8):591-600. PubMed ID: 37586349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease.
    Zhu Y; Wang L; Sun Y; Wang J; Lv C; You H; Xu L; Wang F; Zhang M; Tan W; Ke Y
    Clin Exp Rheumatol; 2022 Feb; 40(2):292-297. PubMed ID: 34874831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.
    d'Alessandro M; Bergantini L; Cavallaro D; Gangi S; Cameli P; Conticini E; Siena Covid Unit ; Frediani B; Dotta F; Bargagli E
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases.
    Cho EJ; Park KJ; Ko DH; Koo HJ; Lee SM; Song JW; Lee W; Lee HK; Do KH; Chun S; Min WK
    Ann Lab Med; 2019 May; 39(3):245-251. PubMed ID: 30623616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of Krebs von den Lungen-6 and Surfactant Protein-A Levels in the Patients with Interstitial Lung Disease.
    Zheng P; Zheng X; Takehiro H; Cheng ZJ; Wang J; Xue M; Lin Q; Huang Z; Huang H; Liao C; Sun B
    J Transl Int Med; 2021 Sep; 9(3):212-222. PubMed ID: 34900632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
    Rai M; Parthasarathi A; Beeraka NM; Kaleem Ullah M; Malamardi S; Padukudru S; Siddaiah JB; Uthaiah CA; Vishwanath P; Chaya SK; Ramaswamy S; Upadhyay S; Ganguly K; Mahesh PA
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality.
    Scarpati G; Baldassarre D; Boffardi M; Calabrese V; De Robertis E; Lacava G; Oliva F; Pagliano P; Pascale G; Tripepi GL; Piazza O
    J Anesth Analg Crit Care; 2022 Aug; 2(1):37. PubMed ID: 37386665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019.
    Yamaya T; Hagiwara E; Baba T; Kitayama T; Murohashi K; Higa K; Sato Y; Otoshi R; Tabata E; Shintani R; Okabayashi H; Ikeda S; Niwa T; Nakazawa A; Oda T; Okuda R; Sekine A; Kitamura H; Komatsu S; Ogura T
    Respir Investig; 2021 Sep; 59(5):596-601. PubMed ID: 33965361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients.
    D'Agnano V; Scialò F; Perna F; Atripaldi L; Sanduzzi S; Allocca V; Vitale M; Pastore L; Bianco A; Perrotta F
    Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.
    Shigemura M; Nasuhara Y; Konno S; Shimizu C; Matsuno K; Yamguchi E; Nishimura M
    J Transl Med; 2012 Jul; 10():111. PubMed ID: 22650152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.
    Mostafa AI; Salem AE; Ahmed HAM; Bayoumi AI; Halim RMA; Samie RMA
    Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):200-208. PubMed ID: 33840176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis.
    He J; Zhang J; Ren X
    Front Immunol; 2022; 13():1041098. PubMed ID: 36532009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could KL-6 levels in COVID-19 help to predict lung disease?
    Frix AN; Schoneveld L; Ladang A; Henket M; Duysinx B; Vaillant F; Misset B; Moutschen M; Louis R; Cavalier E; Guiot J
    Respir Res; 2020 Nov; 21(1):309. PubMed ID: 33234132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.
    Takanashi S; Nishina N; Nakazawa M; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2019 Jun; 58(6):1034-1039. PubMed ID: 30624752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis.
    d'Alessandro M; Bellisai F; Bergantini L; Cameli P; D'Alessandro R; Mazzei MA; Gentili F; Conticini E; Selvi E; Frediani B; Matucci-Cerinic M; Bargagli E
    Eur J Clin Invest; 2021 Aug; 51(8):e13543. PubMed ID: 33759179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
    Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
    BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.